A novel noncanonical signaling pathway for the μ-opioid receptor.
- Authors
- Zhang, Lei; Loh, Horace H; Law, Ping-Yee
- Year
- 2013
- Journal
- Molecular pharmacology
- PMID
- 24061856
- DOI
- 10.1124/mol.113.088278
- PMCID
- PMC3834144
The µ-opioid receptor (OPRM1) signals as a classic G protein-coupled receptor by activating heterotrimeric Gi/Go proteins resulting in adenylyl cyclase (AC) inhibition. Such AC inhibition is desensitized after prolonged agonist treatment. However, after receptor desensitization, the intracellular cAMP level remains regulated by OPRM1, as demonstrated by the intracellular cAMP level increase or AC superactivation upon removal of an agonist or addition of an antagonist. We now demonstrate that such intracellular cAMP regulation is mediated by a novel noncanonical signaling pathway resulting from OPRM1 being converted to a receptor tyrosine kinase (RTK)-like entity. This noncanonical OPRM1 signaling is initiated by the receptor recruiting and activating Src kinase within the receptor complex, leading to phosphorylation of the OPRM1 Tyr(336) residue. Phospho-Tyr(336) serves as the docking site for growth factor receptor-bound protein/son of sevenless, leading to the recruitment and activation of the Ras/Raf-1 and subsequent phosphorylation and activation of AC5/6 by Raf-1. Such sequence of events was established by the absence of Ras/Raf1 recruitment and activation by the OPRM1-Y336F mutant, by the presence of Src kinase inhibitor 4-amino-5-(4-chlorophenyl)-7-(t-butyl)pyrazolo[3,4-d]pyrimidine (PP2) or the absence of Src activity, by the presence of specific Raf-1 inhibitor GW5074 (5-iodo-3-[(3,5-dibromo-4-hydroxyphenyl) methylene]-2-indolinone) or the absence of Raf-1, or by the dominant negative RasN17 mutant. Src together with Ras activates Raf1 which was established by the inability of the Raf1-Tyr(340/341) mutant to activate AC. Hence, the phosphorylation of OPRM1 at Tyr(336) by Src serves as the trigger for the conversion of a classic Gi/Go-coupled receptor into an RTK-like entity, resulting in a noncanonical pathway even after the original Gi/Go signals are blunted.
No figures extracted from this document.
No chunks — full text not yet ingested.
No entities extracted from this document yet.
No uploaded files.
No citations found.
In this knowledge base
| Title | Year | PMID |
|---|---|---|
| KAT2B polymorphism identified for drug abuse in African Americans with regulatory links to drug abuse pathways in human prefrontal cortex. | 2016 | 26202629 |
External
| Title | Authors | Journal | Year | Link |
|---|---|---|---|---|
| Genetic and epigenetic studies of opioid abuse disorder - the potential for future diagnostics. | Abdulmalek S et al. | — | 2023 | → |
| Inverse agonism of lysophospholipids with cationic head groups at Gi-coupled receptor GPR82. | Yasuda D et al. | — | 2023 | → |
| Opioid receptors signaling network. | Gopalakrishnan L et al. | — | 2022 | → |
| Can Src protein tyrosine kinase inhibitors be combined with opioid analgesics? Src and opioid-induced tolerance, hyperalgesia and addiction. | Li Y et al. | — | 2021 | → |
| Comprehensive Signaling Profiles Reveal Unsuspected Functional Selectivity of δ-Opioid Receptor Agonists and Allow the Identification of Ligands with the Greatest Potential for Inducing Cyclase Superactivation. | Mansour A et al. | — | 2021 | → |
| New insights into molecular pathways in colorectal cancer: Adiponectin, interleukin-6 and opioid signaling. | Świerczyński M et al. | — | 2021 | → |
| Depolarization-Dependent C-Raf Signaling Promotes Hyperexcitability and Reduces Opioid Sensitivity of Isolated Nociceptors after Spinal Cord Injury. | Garza Carbajal A et al. | — | 2020 | → |
| Opioid receptor modulation of neural circuits in depression: What can be learned from preclinical data? | Puryear CB et al. | — | 2020 | → |
| Phosphorylation of unique C-terminal sites of the mu-opioid receptor variants 1B2 and 1C1 influences their Gs association following chronic morphine. | Chakrabarti S et al. | — | 2020 | → |
| Recent advances in understanding the molecular mechanisms of cholestatic pruritus: A review. | Sanjel B et al. | — | 2020 | → |
| Nitric oxide modulates μ-opioid receptor function in vitro. | Huang L et al. | — | 2019 | → |
| On resin click-chemistry-mediated synthesis of novel enkephalin analogues with potent anti-nociceptive activity. | Stefanucci A et al. | — | 2019 | → |
| Novel Roles of Non-Coding RNAs in Opioid Signaling and Cardioprotection. | Melo Z et al. | — | 2018 | → |
| Role of GPCR (mu-opioid)-receptor tyrosine kinase (epidermal growth factor) crosstalk in opioid-induced hyperalgesic priming (type II). | Araldi D et al. | — | 2018 | → |
| Withdrawal from spinal application of remifentanil induces long-term potentiation of c-fiber-evoked field potentials by activation of Src family kinases in spinal microglia. | Yang T et al. | — | 2018 | → |
| Site-Specific Regulation of P2X7 Receptor Function in Microglia Gates Morphine Analgesic Tolerance. | Leduc-Pessah H et al. | — | 2017 | → |
| Src-dependent phosphorylation of μ-opioid receptor at Tyr<sup>336</sup> modulates opiate withdrawal. | Zhang L et al. | — | 2017 | → |
| Allostatic Mechanisms of Opioid Tolerance Beyond Desensitization and Downregulation. | Cahill CM et al. | — | 2016 | → |
| Expression and physiology of opioid receptors in the gastrointestinal tract. | Mosińska P et al. | — | 2016 | → |
| KAT2B polymorphism identified for drug abuse in African Americans with regulatory links to drug abuse pathways in human prefrontal cortex. | Johnson EO et al. | — | 2016 | → |
| Selective up-regulation of functional mu-opioid receptor splice variants by chronic opioids. | Chakrabarti S et al. | — | 2016 | → |
| Cellular signalling of non-synonymous single-nucleotide polymorphisms of the human μ-opioid receptor (OPRM1). | Knapman A et al. | — | 2015 | → |
| Gα(i/o)-coupled receptor-mediated sensitization of adenylyl cyclase: 40 years later. | Brust TF et al. | — | 2015 | → |
| Positive allosteric modulators of the μ-opioid receptor: a novel approach for future pain medications. | Burford NT et al. | — | 2015 | → |
| Endogenous opiates and behavior: 2013. | Bodnar RJ | — | 2014 | → |
| Opioid receptor desensitization: mechanisms and its link to tolerance. | Allouche S et al. | — | 2014 | → |